Skip to content

Intuitive Surgical

US · ISRG #157 by market cap Listed 1970
414.52 +9.76 +2.41%
Live - 5344 symbols - heartbeat 14s ago · 2026-10-08 08:25
Pre-market 413.00 -0.37%
After-hours 414.55 +0.01%
Overnight 412.78 -0.42%
Market cap
146.44B
P/B
8.06
EPS
7.87
Reader sentiment Are you bullish or bearish on ISRG?

Anonymous reader poll. Unscientific, not investment advice.

Analyst consensus 21 analysts

Buy
Avg price target 489.95 +18.2%
Price target rangecurrent 414.52
Low391.00
Avg489.95
High685.00
Buy 86% Hold 14% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-09-21 BofA Securities -- BUY 470.00
2026-09-14 BofA Securities -- BUY 470.00
2026-09-07 BTIG -- BUY 469.00
2026-08-28 BMO Capital -- BUY --
2026-08-21 Piper Sandler -- BUY 470.00
2026-08-13 Citi -- BUY 500.00
2026-08-12 Oppenheimer -- BUY 500.00
2026-08-11 Bernstein -- BUY 685.00
2026-08-11 Piper Sandler -- BUY 470.00
2026-08-11 BofA Securities -- BUY 470.00
2026-08-03 TD Cowen -- BUY 485.00
2026-07-30 HSBC -- HOLD 391.00
2026-07-28 UBS -- BUY 500.00
2026-07-28 BMO Capital -- BUY 518.00
2026-07-24 Citi -- BUY --
2026-07-23 Wells Fargo -- BUY 487.00
2026-07-21 J.P. Morgan -- BUY 450.00
2026-07-20 BofA Securities -- BUY 470.00
2026-07-20 BMO Capital -- BUY 518.00
2026-07-19 BMO Capital -- BUY 518.00
2026-07-17 TD Cowen -- BUY 485.00
2026-07-17 Wells Fargo -- BUY 487.00
2026-07-17 Bernstein -- BUY 685.00
2026-07-17 William Blair -- BUY --
2026-07-17 Piper Sandler -- BUY 470.00

Quant vs Street three independent views, side by side

StockVane factor grade
A-
Momentum strategy signal
Sell
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Price target trend monthly average, last 3 years

✦ Quant Analyst Revision Trend how this is computed

Improving
3 1
■ Upgrades■ Downgrades
  • 3 upgrades vs 1 downgrade among tracked analyst rating changes.
  • Most recent: Oppenheimer moved from Hold to Buy on 2026-08-12.

Recent rating changes

DateFirmChangeTarget
2026-08-12 Oppenheimer HOLD → BUY 500.00
2026-07-28 UBS HOLD → BUY 500.00
2026-03-11 Citi HOLD → BUY 590.00
2025-12-11 Citi BUY → HOLD 635.00

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q2 2026-07-16 After close ±8.13% -14.15% (beat)
2026/Q1 2026-04-21 After close ±7.14% +7.16% (beat)
2025/Q4 2026-01-22 After close ±5.46% -0.35% (in line)
2025/Q3 2025-10-21 After close ±7.30% +13.89% (beat)
2025/Q2 2025-07-22 After close ±6.78% -1.77% (in line)
2025/Q1 2025-04-22 After close ±7.87% +1.92% (in line)
2024/Q4 2025-01-23 After close ±6.32% -4.04% (in line)
2024/Q3 2024-10-17 After close ±6.82% +10.01% (beat)
2024/Q2 2024-07-18 After close ±6.80% +9.34% (beat)
2023/Q4 2024-01-23 After close ±5.45% -0.36% (in line)
2023/Q3 2023-10-19 After close ±8.42% -2.39% (in line)
2023/Q2 2023-07-20 After close ±6.93% -3.16% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-10-08 08:25:09 · For reference only, not investment advice and not tailored to your situation.